Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares Issued
Ratios

Pediatrix Medical (MD) Depreciation & Amortization (IS) (2016 - 2025)

Pediatrix Medical (MD) has disclosed Depreciation & Amortization (IS) for 17 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 18.07% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.8 million, a 32.27% decrease, with the full-year FY2025 number at $21.8 million, down 32.27% from a year prior.
  • Depreciation & Amortization (IS) was $5.6 million for Q4 2025 at Pediatrix Medical, up from $5.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $10.3 million in Q1 2024 to a low of $5.3 million in Q2 2025.
  • A 5-year average of $7.9 million and a median of $8.5 million in 2021 define the central range for Depreciation & Amortization (IS).
  • Peak YoY movement for Depreciation & Amortization (IS): increased 20.07% in 2021, then plummeted 48.27% in 2025.
  • Pediatrix Medical's Depreciation & Amortization (IS) stood at $7.9 million in 2021, then increased by 16.25% to $9.1 million in 2022, then fell by 0.81% to $9.1 million in 2023, then decreased by 24.16% to $6.9 million in 2024, then decreased by 18.07% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Depreciation & Amortization (IS) are $5.6 million (Q4 2025), $5.6 million (Q3 2025), and $5.3 million (Q2 2025).